Novel Laboratories Recalls Zolpidem Tartrate Blister Packs Due to Failure to Meet Child-Resistant Closure Requirement; Risk of Poisoning

Active Recall Announced July 27, 2016 CPSC #16232

Quick answer

Novel Laboratories Recalls Zolpidem Tartrate Blister Packs Due to Failure to Meet Child-Resistant Closure Requirement; Risk of Poisoning is CPSC recall #16232, announced on July 27, 2016. The CPSC cites the following hazard: This recall involves 1.75 mg and 3.5 mg Zolpidem Tartrate sublingual (rapid dissolve) tablets from Novel Laboratories. The prescription medication is a sleep drug. The packaging for the 1.75 mg tablets has lot number M16140A, 1.75 mg and national drug code (NDC) 43386-762-30. The packaging for the 3.5 mg tablets has lot number M16144A, 3.5mg and national drug code (NDC) 43386-761-30. The Zolpidem Tartrate is packaged as a single tablet in a peel-and-push blister pack inside an outer open-ended pouch with 30 pouches per box. The lot number and an expiration date of 02/2018 are printed on the bottom left of the pouches. The NDC is printed on the top left corner of the boxes. "Gavis" is printed in blue on the center of the white boxes and pouches. The remedy is consumers should immediately stop using the recalled tablets and contact novel laboratories for instructions to receive a full refund.. Affected brands: Novel Laboratories, Gavis Pharmaceuticals.

Hazard

This recall involves 1.75 mg and 3.5 mg Zolpidem Tartrate sublingual (rapid dissolve) tablets from Novel Laboratories. The prescription medication is a sleep drug. The packaging for the 1.75 mg tablets has lot number M16140A, 1.75 mg and national drug code (NDC) 43386-762-30. The packaging for the 3.5 mg tablets has lot number M16144A, 3.5mg and national drug code (NDC) 43386-761-30. The Zolpidem Tartrate is packaged as a single tablet in a peel-and-push blister pack inside an outer open-ended pouch with 30 pouches per box. The lot number and an expiration date of 02/2018 are printed on the bottom left of the pouches. The NDC is printed on the top left corner of the boxes. "Gavis" is printed in blue on the center of the white boxes and pouches.

Affected products

Zolpidem Tartrate Sublingual tablets

Recalled brands

Novel Laboratories, Gavis Pharmaceuticals

Remedy

Consumers should immediately stop using the recalled tablets and contact Novel Laboratories for instructions to receive a full refund.

Recall date

July 27, 2016

Categories

Tablet or Capsule Drugs

Frequently asked questions

What is CPSC recall #16232?

CPSC recall #16232 covers Novel Laboratories Recalls Zolpidem Tartrate Blister Packs Due to Failure to Meet Child-Resistant Closure Requirement; Risk of Poisoning, announced by the U.S. Consumer Product Safety Commission on July 27, 2016. The CPSC cites the following hazard: This recall involves 1.75 mg and 3.5 mg Zolpidem Tartrate sublingual (rapid dissolve) tablets from Novel Laboratories. The prescription medication is a sleep drug. The packaging for the 1.75 mg tablets has lot number M16140A, 1.75 mg and national drug code (NDC) 43386-762-30. The packaging for the 3.5 mg tablets has lot number M16144A, 3.5mg and national drug code (NDC) 43386-761-30. The Zolpidem Tartrate is packaged as a single tablet in a peel-and-push blister pack inside an outer open-ended pouch with 30 pouches per box. The lot number and an expiration date of 02/2018 are printed on the bottom left of the pouches. The NDC is printed on the top left corner of the boxes. "Gavis" is printed in blue on the center of the white boxes and pouches.

What is the remedy for recall #16232?

The CPSC remedy for recall #16232 is consumers should immediately stop using the recalled tablets and contact novel laboratories for instructions to receive a full refund.. Consumers should stop using the product and follow the instructions in the official CPSC notice.

I sell this product on Shopify. What do I need to do?

If you sell Novel Laboratories Recalls Zolpidem Tartrate Blister Packs Due to Failure to Meet Child-Resistant Closure Requirement; Risk of Poisoning on Shopify, stop selling the affected units immediately, notify customers who purchased them, and consider whether you have a Section 15(b) reporting obligation to the CPSC. RecallDocket helps Shopify merchants identify affected SKUs and prepare the required safety report.

Where is the official CPSC notice for this recall?

The primary source is the official CPSC notice at https://www.cpsc.gov/Recalls/2016/Novel-Laboratories-Recalls-Zolpidem-Tartrate-Blister-Packs. RecallDocket links to it from this page.

Not legal advice. RecallDocket aggregates publicly available recall information from the U.S. Consumer Product Safety Commission for informational purposes only. For the official notice, remedy instructions, and any safety actions, refer to the CPSC source. Information may be incomplete or out of date.

Sell on Shopify? Stay ahead of every CPSC recall.

RecallDocket automatically checks your catalog against new CPSC recalls and alerts you the moment one of your products is affected.

Install RecallDocket — free
← Back to all recalls